Greehey Children's Cancer Research Institute

Medicine & Life Sciences

1. Neoplasms 100%
2. RNA-Binding Proteins 58%
3. MicroRNAs 56%
4. Genes 56%
5. Breast Neoplasms 48%
6. Growth 44%
7. Proteins 44%
8. Rhabdomyosarcoma 39%
9. RNA 38%
10. Pediatrics 36%
11. Glioblastoma 36%
12. Heterografts 35%
13. Messenger RNA 34%
14. Proteomics 33%
15. Stem Cells 32%
16. Ewing's Sarcoma 31%
17. Neoplasm Metastasis 28%
18. Transforming Growth Factors 27%
19. Gene Expression 27%
20. Apoptosis 24%
21. Carcinogenesis 23%
22. Estrogen Receptors 22%
23. Cell Line 22%
24. DNA 22%
25. RNA Sequence Analysis 22%
26. Therapeutics 22%
27. Methylation 20%
28. Breast 19%
29. Genome 19%
30. Mutation 19%
31. Down-Regulation 18%
32. Cell Differentiation 18%
33. Cell Survival 17%
34. Lung Neoplasms 17%
35. Osteosarcoma 17%
36. Transcriptome 16%
37. Hispanic Americans 16%
38. Angiostatins 16%
39. Glioma 16%
40. Sarcoma 15%
41. Prostatic Neoplasms 15%
42. Neuroblastoma 15%
43. Medulloblastoma 15%
44. Gastrointestinal Microbiome 14%
45. Transcription Factors 14%
46. Phenobarbital 14%
47. Non-Small Cell Lung Carcinoma 14%
48. Sertoli Cells 14%
49. In Vitro Techniques 14%
50. Human Mammary Glands 14%
51. Carrier Proteins 13%
52. Gene Regulatory Networks 13%
53. Cytochrome P-450 Enzyme System 13%
54. Ubiquitination 13%
55. Cell Proliferation 13%
56. DNA Repair 13%
57. Survival 13%
58. Phenotype 13%
59. Myeloid Leukemia 13%
60. Epigenome 13%
61. Neoplastic Stem Cells 12%
62. Wilms Tumor 12%
63. Hypoxia 12%
64. Oncogenes 12%
65. Epigenomics 12%
66. Vincristine 12%
67. Mass Spectrometry 11%
68. DNA Methylation 11%
69. Cell Cycle 11%
70. Germ Cells 11%
71. B-Lymphocytes 11%
72. Precursor Cell Lymphoblastic Leukemia-Lymphoma 11%
73. Cytochrome P-450 CYP2B1 11%
74. Immunoprecipitation 11%
75. Prostate 11%
76. Chromatin 11%
77. Zucker Rats 10%
78. Long Noncoding RNA 10%
79. Radiation 10%
80. Androgens 10%
81. Microbiota 10%
82. Enzymes 10%
83. Protein Isoforms 10%
84. Enzyme Induction 10%
85. Child 10%
86. Sirolimus 10%
87. Triple Negative Breast Neoplasms 9%
88. Human Genome 9%
89. talazoparib 9%
90. Astrocytes 9%
91. Leukemia 9%
92. Epithelial Cells 9%
93. Discoidin Domain Receptor 2 9%
94. Population 9%
95. Pharmaceutical Preparations 9%
96. Hepatocellular Carcinoma 9%
97. Treponema denticola 9%
98. 3' Untranslated Regions 9%
99. Recurrence 8%
100. Drug Therapy 8%